Regulation of insulin secretion and β-cell mass by activating signal cointegrator 2

Molecular and Cellular Biology

Volumn 26, Issue 12, 2006, Pages 4553-4563

  Yeom, Seon Yong ^a   Kim, Geun Hyang ^a   Kim, Chan Hee ^a   Jung, Heun Don ^a   Kim, So Yeon ^b   Park, Joong Yeol ^a   Pak, Youngmi Kim ^a   Rhee, Dong Kwon ^c   Kuang, Shao Qing ^d   Xu, Jianming ^d   Han, Duck Jong ^a   Song, Dae Kyu ^b   Lee, Jae Woon ^d   Lee, Ki Up ^a   Kim, Seung Whan ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING SIGNAL COINTEGRATOR 2; AMINO ACID; CELL NUCLEUS RECEPTOR; INSULIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EXOCRINE CELL; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RAT;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL PROLIFERATION; DNA; GENE EXPRESSION; GLUCOSE; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; RATS; RATS, INBRED OLETF; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 33745069423     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01412-05     Document Type: Article

References (62)

1. Ahlgren, U., J. Jonsson, L. Jonsson, K. Simu, and H. Edlund. 1998. β-Cell specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes. Genes Dev. 12:1763-1768.
2. Antonson, P., G. U. Schuster, L. Wang, B. Rozell, E. Holter, P. Flodby, E. Treuter, L. Holmgren, and J.-Å. Gustafsson. 2003. Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol. Cell. Biol. 23:1260-1268.
3. Bell, G. I., S. J. Pilkis, I. T. Weber, and K. S. Polonsky. 1996. Glucokinase mutations, insulin secretion, and diabetes mellitus. Annu. Rev. Physiol. 58:171-186.
4. Brissova, M., M. Shiota, W. E. Nicholson, M. Gannon, S. M. Knobel, D. W. Piston, C. V. Wright, and A. C. Powers. 2002. Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J. Biol. Chem. 227:11225-11232.
5. Caira, F., P. Antonson, M. Pelto-Huikko, E. Treuter, and J.-Å. Gustafsson. 2000. Cloning and characterization of RAP250, a novel nuclear receptor coactivator. J. Biol. Chem. 275:5308-5317.
6. Chan, C. B., J. M. Lowe, and W. J. Debertin. 1996. Modulation by glucose of insulin secretion and glucose phosphorylating activity in cultured pancreatic islets from obese (fa/fa) Zucker rats. Int. J. Obes. 20:175-184.
7. Deeney, J. T., M. Prentki, and B. E. Corkey. 2000. Metabolic control of β-cell function. Semin. Cell Dev. Biol. 11:267-275.
8. Ding, X. F., C. M. Anderson, H. Ma, H. Hong, R. M. Uht, P. J. Kushner, and M. R. Stallcup. 1998. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12:302-313.
9. Dutta, S., S. Bonner-Weir, M. Montminy, and C. Wright. 1998. Regulatory factor linked to late-onset diabetes? Nature 392:560.
10. Edlund, H. 2002. Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nat. Rev. Genet. 3:524-532.
11. Eeckhoute, J., E. Moerman, T. Bouckenooghe, B. Lukoviak, F. Pattou, P. Formstecher, J. Kerr-Conte, B. Vandewalle, and B. Laine. 2003. Hepatocyte nuclear factor 4α isoforms originated from the P1 promoter are expressed in human pancreatic β-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms. Endocrinology 144:1686-1694.
12. Efanov, A. M., S. Sewing, K. Bokvist, and J. Gromada. 2004. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic β-cells. Diabetes 53:S75-S78.
13. Fajas, L., J.-S. Annicotte, S. Miard, D. Sarruf, M. Watanabe, and J. Auwerx. 2004. Impaired pancreatic growth, β cell mass, and β cell function in E2F1-/- mice. J. Clin. Investig. 113:1288-1295.
14. Georgia, S., and A. Bhushan. 2004. β Cell replication is the primary mechanism for maintaining postnatal β cell mass. J. Clin. Investig. 114:963-968.
15. Gradwohl, G., A. Dierich, M. LeMeur, and F. Guillemot. 2000. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. USA 97:1607-1611.
16. Gupta, R. K., M. Z. Vatamaniuk, C. S. Lee, R. C. Flaschen, J. T. Fulmer, F. M. Matschinsky, S. A. Duncan, and K. H. Kaestner. 2005. The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion. J. Clin. Investig. 115:1006-1015.
17. Hirota, K., H. Daitoku, H. Matsuzaki, N. Araya, K. Yamagata, S. Asada, T. Sugaya, and A. Fukamizu. 2003. Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor. J. Biol. Chem. 278:13056-13060.
18. Horikawa, Y., N. Iwasaki, M. Hara, H. Furuta, Y. Hinokio, B. N. Cockburn, T. Lindner, K. Yamagata, M. Ogata, O. Tomonaga, H. Kuroki, T. Kasahara, Y. Iwamoto, and G. I. Bell. 1997. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat. Genet. 17:384-385.
19. +/- mice. J. Clin. Investig. 111:1147-1160.
20. m glucose transporters in noninsulin-dependent diabetes. Science 250:546-549.
21. Jonsson, J., L. Carlsson, T. Edlund, and H. Edlund. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606-609.
22. Kawano, K., T. Hiroshima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori. 1992. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41:1422-1428.
23. Khan, A., V. Chandramouli, C.-G. Östenson, B. Ahrén, W. C. Schumann, H. Löw, B. R. Landau, and S. Efendić. 1989. Evidence for the presence of glucose cycling in pancreatic islets of the ob/ob mouse. J. Biol. Chem. 264:9732-9733.
24. Kim, S. W., C. Cheong, Y. C. Sohn, Y. H. Goo, W. J. Oh, J. H. Park, S. Y. Joe, H. S. Kang, D. K. Kim, C. Kee, J. W. Lee, and H. W. Lee. 2002. Multiple developmental defects derived from impaired recruitment of ASC-2 to nuclear receptors in mice: implication for posterior lenticonus with cataract. Mol. Cell. Biol. 22:8409-8414.
25. Kim, S. W., K. Park, E. Kwak, E. Choi, S. Lee, J. Ham, H. Kang, J. M. Kim, S. Y. Hwang, Y. Y. Kong, K. Lee, and J. W. Lee. 2003. Activating signal cointegrator 2 required for liver lipid metabolism mediated by liver X receptors in mice. Mol. Cell. Biol. 23:3583-3592.
26. Ko, L., G. R. Cardona, and W. W. Chin. 2000. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator. Proc. Natl. Acad. Sci. USA 97:6212-6217.
27. Kong, H. J., H. J. Yu, S. Hong, M. J. Park, Y. H. Choi, W. G. An, J. W. Lee, and J. Cheong. 2003. Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation. Mol. Cancer Res. 1:948-958.
28. Kuang, S. Q., L. Liao, H. Zhang, F. A. Pereira, Y. Yuan, F. J. DeMayo, L. Ko, and J. Xu. 2002. Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality. J. Biol. Chem. 277:45356-45360.
29. Lee, S.-K., S. L. Anzick, J.-E. Choi, L. Bubendorf, X.-Y. Guan, Y.-K. Jung, O. P. Kallioniemi, J. Kononen, J. M. Trent, D. Azorsa, B.-H. Jhun, J. H. Cheong, Y. C. Lee, P. S. Meltzer, and J. W. Lee. 1999. A nuclear factor, ASC-2, is a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J. Biol. Chem. 274:34283-34293.
30. Lee, S.-K., S.-Y. Jung, Y.-S. Kim, S.-Y. Na, Y. C. Lee, and J. W. Lee. 2001. Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2. Mol. Endocrinol. 15:241-254.
31. -Delta;ΔCT method. Methods 25:402-408.
32. Lottmann, H., J. Vanselow, B. Hessabi, and R. Walther. 2001. The Tet-On system in transgenic mice: inhibition of the mouse pdx-1 gene activity by antisense RNA expression in pancreatic β-cells. J. Mol. Med. 79:321-328.
33. Mahajan, M. A., and H. H. Samuels. 2005. Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development. Endocr. Rev. 26:583-597.
34. Mahajan, M. A., and H. H. Samuels. 2000. A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein. Mol. Cell. Biol. 20:5048-5063.
35. Mahajan, M. A., S. Das, H. Zhu, M. Tomic-Canic, and H. H. Samuels. 2004. The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Mol. Cell. Biol. 24:4994-5004.
36. Malecki, M. T., U. S. Jhala, A. Antonellis, L. Fields, A. Doria, T. Orban, M. Saad, J. H. Warram, M. Montminy, and A. S. Krolewski. 1999. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat. Genet. 23:323-328.
37. Meglasson, M. D., P. T. Burch, D. K. Berner, H. Najafi, and F. M. Matschinsky. 1986. Identification of glucokinase as an alloxan-sensitive glucose sensor of the pancreatic β-cell. Diabetes 35:1163-1173.
38. Minn, A. H., C. Hafele, and A. Shalev. 2005. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces β-cell apoptosis. Endocrinology 146:2397-2405.
39. Moates, J. M., S. Nanda, M. A. Cissell, M.-J. Tsai, and R. Stein. 2003. BETA2 activates transcription from the upstream glucokinase gene promoter in islet β-cells and gut endocrine cells. Diabetes 52:403-408.
40. Naya, F. J., H. P. Huang, Y. Qiu, H. Mutoh, F. J. DeMayo, A. B. Leiter, and M. J. Tsai. 1997. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 11:2323-2334.
41. Orlando, V., H. Strutt, and R. Paro. 1997. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11:205-214.
42. Östenson, C. G., A. Khan, S. M. Abdel-Halim, A. Guenifi, K. Suzuki, Y. Goto, and S. Efendić. 1993. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia 36:3-8.
43. Qi, C., P. Kashireddy, Y. T. Zhu, S. M. Rao, and Y. J. Zhu. 2004. Null mutation of peroxisome proliferator-activated receptor-interacting protein in mammary glands causes defective mammopoiesis. J. Biol. Chem. 279:33696-33701.
44. Ronner, P., E. Friel, K. Czerniawski, and S. Frankle. 1999. Luminometric assays of ATP, phosphocreatin, and creatin for estimation of free ADP and free AMP. Anal. Biochem. 275:208-216.
45. Roth, U., K. Jungermann, and T. Kietzmann. 2002. Activation of glucokinase gene expression by hepatic nuclear factor 4 α in primary hepatocytes. Biochem. J. 365:223-228.
46. Sohn, Y. C., E. Kwak, Y. Na, J. W. Lee, and S. K. Lee. 2001. Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77. J. Biol. Chem. 276:43734-43739.
47. Sosa-Pineda, B., K. Chowdhury, M. Torres, G. Oliver, and P. Gruss. 1997. The Pax4 gene is essential for differentiation of insulin-producing β-cells in the mammalian pancreas. Nature 386:399-402.
48. Stoffers, D. A., J. Ferrer, W. L. Clarke, and J. F. Habener. 1997. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17:138-139.
49. Sturis, J., W. L. Pugh, J. Tang, D. M. Ostrega, J. S. Polonsky, and K. S. Polonsky. 1994. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat. Am. J. Physiol. Endocrinol. Metab. 267:E250-E259.
50. Sussel, L., J. Kalamaras, D. J. Hartigan-O'Connor, J. J. Meneses, R. A. Pedersen, J. L. Rubenstein, and M. S. German. 1998. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic β-cells. Development 125:2213-2221.
51. Suzuki, K., S. Bonner-Weir, J. Hollister, and G. C. Weir. 1996. A method for estimating number and mass of islets transplanted within a membrane device. Cell Transplant. 5:613-625.
52. Taylor, S. I. 1999. Deconstructing type 2 diabetes. Cell 97:9-12.
53. Thomas, M. K., O. N. Devon, J. H. Lee, A. Peter, D. A. Schlosser, M. S. Tenser, and J. F. Habener. 2001. Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J. Clin. Investig. 108:319-329.
54. Tokuyama, Y., J. Sturis, A. M. DePaoli, J. Takeda, M. Stoffel, J. Tang, X. Sun, K. S. Polonsky, and G. I. Bell. 1995. Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447-1457.
55. Toresson, G., G. U. Schuster, K. R. Steffensen, M. Bengtsson, J. Ljunggren, K. Dahlman-Wright, and J.-Å. Gustafsson. 2004. Purification of functional full-length liver X receptor β produced in Escherichia coli. Protein Expr. Purif. 35:190-198.
56. Trinh, K., C. Minassian, A. J. Lange, R. M. O'Doherty, and C. B. Newgard. 1997. Adenovirus-mediated expression of the catalytic subunit of glucose-6-phosphatase in INS-1 cells. J. Biol. Chem. 272:24837-24842.
57. Yamagata, K., H. Furuta, N. Oda, P. J. Kaisaki, S. Menzel, N. J. Cox, S. S. Fajans, S. Signorini, M. Stoffel, and G. I. Bell. 1996. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460.
58. Yamagata, K., N. Oda, P. J. Kaisaki, S. Menzel, H. Furuta, M. Vaxillaire, L. Southam, R. D. Cox, G. M. Lathrop, V. V. Boriraj, X. Chen, N. J. Cox, Y. Oda, H. Yano, M. M. Le Beau, S. Yamada, H. Nishigori, J. Takeda, S. S. Fajans, A. T. Hattersley, N. Iwasaki, T. Hansen, O. Pedersen, K. S. Polonsky, R. C. Turner, G. Velho, J.-C. Chèvre, P. Froguel, and G. I. Bell. 1996. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458.
59. Yoon, J. C., G. Xu, J. T. Deeney, S. N. Yang, J. Rhee, P. Puigserver, A. R. Levens, R. Yang, C. Y. Zhang, B. B. Lowell, P. O. Berggren, C. B. Newgard, S. Bonner-Weir, G. Weir, and B. M. Spiegelman. 2003. Suppression of β cell energy metabolism and insulin release by PGC-1α. Dev. Cell 5:73-83.
60. Zhang, H., L. Liao, S. Q. Kuang, and J. Xu. 2003. Spatial distribution of the messenger ribonucleic acid and protein of the nuclear receptor coactivator, amplified in breast cancer-3, in mice. Endocrinology 144:1435-1443.
61. Zhu, Y., S. E. Crawford, V. Stellmach, R. S. Dwivedi, M. S. Rao, F. J. Gonzalez, C. Qi, and J. K. Reddy. 2003. Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J. Biol. Chem. 278:1986-1990.
62. Zhu, Y., L. Kan, C. Qi, Y. S. Kanwar, A. V. Yeldandi, M. S. Rao, and J. K. Reddy. 2000. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J. Biol. Chem. 275:13510-13516.